HOME > NATION > Article

Text Size

small

medium

large


Japan Team Develops Method to Block Coronavirus Infection

Japan Team Develops Method to Block Coronavirus Infection

   Kyoto, Nov. 19 (Jiji Press)--A Japanese research team has said it developed a method to block novel coronavirus infection by preventing the virus from being attached to receptors on the human cell surface.
   The team, including Kyoto Prefectural University of Medicine, will start a clinical trial within fiscal 2021 to put a drug created with the method into practical use, according to an announcement Wednesday.
   The coronavirus infects humans by attaching itself to the ACE2 receptor protein on the cell surface. The team obtained a protein 100 times more easily bound to the virus than ACE2 by modifying it.
   According to the team, a planned drug based on the new ACE2 protein is expected to lower the infectious capacity of the virus and help prevent COVID-19 patients from becoming seriously ill.
   The novel coronavirus easily mutates. Antibody drugs that have worked may become ineffective after a mutation.

To read a full story, please click here to find out how to subscribe.

NATION

Aomori Tourism Information

HEADLINES

POLITICS
US Tightens Visa Rules for Communist Party of China Members, Families
ECONOMY
Japan Book Market to See 1st Growth in 4 Yrs in 2020 Thanks to "Demon Slayer"
SPORTS
Asian Soccer: FC Tokyo Clinch 1st Champions League Knockout Stage Spot in 4 Yrs
OTHER
Bill Gates Foundation to Support Japan Firms in Coronavirus Vaccine Supplies

AFP-JIJI PRESS NEWS JOURNAL


Photos